Study shows targeted therapeutic after chemotherapy kills transitional cancer cells

[News]

Timing may be decisive when it comes to overcoming cancer's ability to evade treatment. By hitting breast cancer cells with a targeted therapeutic immediately after chemotherapy, researchers from Brigham and Women's Hospital (BWH) were able to target cancer cells during a transitional stage when they were most vulnerable, killing cells and shrinking tumors in the lab and in pre-clinical models.

More... (http://www.news-medical.net/news/20150212/Study-shows-targeted-therapeutic-after-chemotherapy-kills-transitional-cancer-cells.aspx)